Study to Assess an Anti-Trop2 Antibody Drug Conjugate in Relapsed or Refractory Solid Tumors

Clinical trial NCT05060276 · WITHDRAWN

Trial details

NCT number: NCT05060276
Sponsor: Sorrento Therapeutics, Inc.
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed Solid Neoplasm Refractory Cancer Solid Tumor, Adult

Start date: 2022-12-01
Primary completion: 2024-05-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.